scandal
GSK to reintroduce bonuses for sales reps
May 24, 2019Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal
British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …
J&J announces $5bn share repurchase
December 18, 2018Manufacturing and Production J&J, JJ, Shares, asbestos, baby powder, reuters, scandal
New Jersey-based pharma firm Johnson & Johnson plans to buy back $5 billion in shares after news agency Reuters released …
Top Ten most popular articles on Pharmafile.com this week
September 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10
Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …
Further six officials fired from China FDA
August 21, 2018Manufacturing and Production CFDA, Changsheng biotechnology, China, Vaccine, scandal
A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the …
Chinese premier slams drug maker after vaccine scandal
July 23, 2018Sales and Marketing CCP, China, biotech, scandal, vaccines
Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …
“Incorrect classification” of EpiPen leads to $1 billion bill for US government
October 6, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, Heather Bresch, Misclassification, Mylan, Price hike, classification, epipen, price, scandal
Mylan’s EpiPen woes show no sign of abating after CMS (Centers for Medicare and Medicaid Services) released figures that show …
Antitrust investigation launched into Mylan and the EpiPen scandal
September 7, 2016Research and Development, Sales and Marketing Mylan, US, antitrust, epipen, investigation, lawmakers, scandal
The New York attorney general has commenced an investigation into Mylan Pharmaceuticals, after an initial review indicated that the company …
Big investor hits back at critics as Valeant’s war of words gathers pace
May 3, 2016Manufacturing and Production, Sales and Marketing Valeant, ackman, allegations, buffett, practices, price gouging, price rises, scandal
Valeant have hit the mainstream news again after key investor Bill Ackman mounted a robust defence of the company, ruling …
Sticking the boot in
April 18, 2016Sales and Marketing Boots, Cost, Guardian, NHS, prescribing, scandal, unfair
A recent exposé has shone a light on the practices allegedly enforced at the nation’s largest pharmacy. So what exactly …
Valeant ends controversial litigation with R&O Pharmacy
March 10, 2016Litigation, Philidor, Valeant, controversy, r&o pharmacy, scandal
Valeant has announced that, in conjunction with R&O Pharmacy, its has jointly requested that the Court dismiss the litigation between …
GSK investigator freed from Chinese prison
June 10, 2015Medical Communications, Sales and Marketing China, GSK, GlaxoSmithKline, brett wells, bribery, scandal
British private investigator Peter Humphrey who worked for GlaxoSmithKline has been released from a Chinese jail following his conviction last …
Another major drop in sales for GSK
July 23, 2014Sales and Marketing China, GSK, Q2, Witty, bribery, sales, scandal, sex
GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …
Francis report author becomes Patients Association president
November 28, 2013Sales and Marketing Mid Staffs, NHS, robert francis, scandal
The author of a damning report into failings at the Staffordshire hospital has become the new president of the Patients …
NHS Confederation chief executive quits to be a consultant
September 11, 2013Medical Communications, Sales and Marketing Mike Farrar, NHS, scandal
Mike Farrar is to stand down as chief executive of the NHS Confederation at the end of the month in …
GSK admits: Execs ‘breached Chinese law’
July 22, 2013Medical Communications, Sales and Marketing China, GSK, bribes, scandal
A senior GlaxoSmithKline executive has admitted that some of the firm’s staff have broken the law in China as a …
